Getting big for BIO
Tuesday, 06 February, 2007
The March/April 2007 issue of Australian Life Scientist will feature a comprehensive preview of the BIO2007 convention, to be held this year in Boston.
BIO is the world's largest biotechnology gathering, with up to 20,000 delegates expected. The Australian Pavilion, sponsored by Invest Australia, will host over 30 Australian biotech companies, state and territory industry departments and service providers for the biotech and life sciences industries from around the country.
ALS will provide an overview of the biotech sector in Australia, along with a state by state who's who, profiles of some of the best biotech performers in each state and detail on Australia's research organisations, including CSIRO, for an international audience.
The focus will be on the science as well as the share price, providing readers with an in-depth understanding of how the life sciences are moving ahead at breakneck speed in this country.
We will also review the Lorne conferences on protein function and structure, genome and cancer, and will update readers on the most recent developments in RNAi and proteomics. We'll take a look at DNA-directed RNAi, explain a new technique for characterising glycoproteins and using protein fractionation for biomarker discovery.
As always, ALS will feature all of the latest products and methods on the market in Lab News, the latest scientific literature in our Bookshop and local and international conference dates in Events.
Deadlines for the March/April issue:
Editorial submission deadline: February 23
Advertising booking deadline: March 2
Complete advertising material deadline: March 9
Issue date: March 30
Advertising enquiries
For more information about advertising, please contact:
Ric Hudson
Phone: 02 9902 2732
Email: ric_hudson@idg.com.au
Editorial enquiries
For editorial inquiries, please contact:
Kate McDonald
Phone: 02 9902 2765
Email: kate_mcdonald@idg.com.au
Shingles vaccine may lower risk of dementia, heart disease
It turns out that the shingles vaccine may have public-health benefits beyond its intended...
How does the brain evaluate rewards?
Neuroscientists have shown how nerve cells in the amygdala not only encode the probability and...
Breakthrough drug prevents long COVID symptoms in mice
Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...